In-Hospital Peak Glycemia in Predicting No-Reflow Phenomenon in Diabetic Patients with STEMI Treated with Primary Percutaneous Coronary Intervention
Although percutaneous coronary intervention (PCI) significantly improves the prognosis for myocardial infarction, the no-reflow phenomenon is still the major adverse complication of PCI leading to increased mortality, especially for the patients with ST-segment elevation myocardial infarction (STEMI...
Saved in:
Main Authors: | Fang Liu, Rui Huang, Ya Li, Surui Zhao, Yue Gong, Zesheng Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2021/6683937 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
«No-reflow» phenomenon and risk factors associated with its development after primary percutaneous coronary interventions in patients with ST elevation myocardial infarction
by: V.І. Tseluyko, et al.
Published: (2018-09-01) -
Research progress on coronary slow flow or no-reflow of coronary heart disease undergoing percutaneous coronary intervention surgery
by: Mengdi Wang, et al.
Published: (2025-01-01) -
No-Reflow Phenomenon and Endothelial Glycocalyx of Microcirculation
by: Alexander V. Maksimenko, et al.
Published: (2012-01-01) -
Predictive Value of Soluble Growth Stimulator Gene 2 Protein for Coronary Slow Flow/No-Reflow in ST-Elevation Myocardial Infarction Patients Receiving Percutaneous Coronary Intervention
by: Shu-min Chang, et al.
Published: (2022-01-01) -
Association between Peak Neutrophil Count, Clopidogrel Loading Dose, and Left Ventricular Systolic Function in Patients with Primary Percutaneous Coronary Intervention
by: Xinyu Wang, et al.
Published: (2014-01-01)